These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16980204)

  • 61. [Clinical and laboratory features of hereditary pheochromocytoma and paraganglioma].
    Rebrova DV; Vorokhobina NV; Imyanitov EN; Rusakov VF; Krasnov LM; Sleptsov IV; Chernikov RA; Fedorov EA; Semenov AA; Chinchuk IK; Sablin IV; Alekseev MA; Kuleshov OV; Fedotov JN
    Probl Endokrinol (Mosk); 2021 Nov; 68(1):8-17. PubMed ID: 35262293
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Familial risk for neuroendocrine tumors.
    Anderson RJ; Lynch HT
    Curr Opin Oncol; 1993 Jan; 5(1):75-84. PubMed ID: 8094015
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phaeochromocytoma in children.
    Yeung LP; Kwan EY; Cheung PT; Low LC
    Hong Kong Med J; 2002 Dec; 8(6):452-5. PubMed ID: 12459603
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [C634R mutation of the protooncongene RET and molecular diagnosis in multiple endocrine neoplasia type 2 in a large Moroccan family].
    Benazzouz B; Hafidi A; Benkhira S; Chraibi A; Kadiri A; Hilal L
    Bull Cancer; 2008 Apr; 95(4):457-63. PubMed ID: 18495576
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Cleary S; Phillips JK; Huynh TT; Pacak K; Fliedner S; Elkahloun AG; Munson P; Worrell RA; Eisenhofer G
    Horm Metab Res; 2007 Dec; 39(12):876-83. PubMed ID: 18046660
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of genetics in the surgical management of familial endocrinopathy syndromes.
    Shapiro SE; Cote GC; Lee JE; Gagel RF; Evans DB
    J Am Coll Surg; 2003 Nov; 197(5):818-31. PubMed ID: 14585420
    [No Abstract]   [Full Text] [Related]  

  • 67. Pheochromocytoma: a review.
    Tsirlin A; Oo Y; Sharma R; Kansara A; Gliwa A; Banerji MA
    Maturitas; 2014 Mar; 77(3):229-38. PubMed ID: 24472290
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The genetics of phaeochromocytoma: using clinical features to guide genetic testing.
    Jafri M; Maher ER
    Eur J Endocrinol; 2012 Feb; 166(2):151-8. PubMed ID: 21896620
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Bilateral pheochromocytoma. Genetics and treatment].
    Mirallié E; Cariou B; Kraeber-Bodéré F
    Ann Chir; 2005 Apr; 130(4):273-6. PubMed ID: 15847867
    [No Abstract]   [Full Text] [Related]  

  • 70. Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma.
    Burnichon N; Mazzella JM; Drui D; Amar L; Bertherat J; Coupier I; Delemer B; Guilhem I; Herman P; Kerlan V; Tabarin A; Wion N; Lahlou-Laforet K; Favier J; Gimenez-Roqueplo AP
    J Med Genet; 2017 Feb; 54(2):125-133. PubMed ID: 27856506
    [TBL] [Abstract][Full Text] [Related]  

  • 71. These tumors can be associated with known genetic syndromes, such as the von Hippel-Lindau or multiple endocrine neoplasia 2 syndromes, or they can arise sporadically. Foreword.
    Kummar S
    Curr Probl Cancer; 2014; 38(1):6. PubMed ID: 24636753
    [No Abstract]   [Full Text] [Related]  

  • 72. 65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma.
    Neumann HP; Young WF; Krauss T; Bayley JP; Schiavi F; Opocher G; Boedeker CC; Tirosh A; Castinetti F; Ruf J; Beltsevich D; Walz M; Groeben HT; von Dobschuetz E; Gimm O; Wohllk N; Pfeifer M; Lourenço DM; Peczkowska M; Patocs A; Ngeow J; Makay Ö; Shah NS; Tischler A; Leijon H; Pennelli G; Villar Gómez de Las Heras K; Links TP; Bausch B; Eng C
    Endocr Relat Cancer; 2018 Aug; 25(8):T201-T219. PubMed ID: 29794110
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Genetic diagnosis of phaeochromocytomas and paragangliomas].
    Cardot-Bauters C; Ainaouï M; Coppin L; Pigny P
    Presse Med; 2014 Apr; 43(4 Pt 1):460-7. PubMed ID: 24612707
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].
    Vermalle M; Tabarin A; Castinetti F
    Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S10-S21. PubMed ID: 30213301
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Germline SDHD mutation in familial phaeochromocytoma.
    Astuti D; Douglas F; Lennard TW; Aligianis IA; Woodward ER; Evans DG; Eng C; Latif F; Maher ER
    Lancet; 2001 Apr; 357(9263):1181-2. PubMed ID: 11323050
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Hereditary pheochromocytoma--a family affected by von Hippel-Lindau disease].
    Mertl J; Rovný A; Krepelová A; Prásek J
    Vnitr Lek; 2003 Jul; 49(7):572-5. PubMed ID: 12931443
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumours of familial origin in the head and neck.
    Suárez C; Rodrigo JP; Ferlito A; Cabanillas R; Shaha AR; Rinaldo A
    Oral Oncol; 2006 Nov; 42(10):965-78. PubMed ID: 16857415
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetic testing by cancer site: endocrine system.
    Pilarski R; Nagy R
    Cancer J; 2012; 18(4):364-71. PubMed ID: 22846739
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Genetic background of tumors originating from adrenomedullar and extraadrenal chromaffin tissue--update].
    Vanuga P; Pura M; Kreze A
    Vnitr Lek; 2010 Dec; 56(12):1296-302. PubMed ID: 21261119
    [TBL] [Abstract][Full Text] [Related]  

  • 80. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.